---
title: "Genprex, Inc. (GNPX.US)"
type: "quote"
locale: "en"
url: "https://longbridge.com/en/quote/GNPX.US.md"
symbol: "GNPX.US"
name: "Genprex, Inc."
industry: "Biotechnology"
---

# Genprex, Inc. (GNPX.US)

| Item | Detail |
|------|--------|
| Industry | Biotechnology |
| Location | US Market |
| Website | [www.genprex.com](https://www.genprex.com) |

## Company Profile

Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes. The company’s technologies are designed to administer disease-fighting genes to provide new therapies for patient populations with cancer and diabetes. Its oncology program ut...

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -0.26 | 106/604 | - | - | - |
| PB | 5.62 | 312/604 | 6.42 | 4.08 | 1.89 |
| Dividend Yield | 0.00% | - | - | - | - |

## Institutional View

### Analyst Rating Distribution

> As of 2024-11-19T05:00:00.000Z

Total Analysts: **1**

| Rating | Count | Percentage |
|--------|-------|-----------|
| Buy | 1 | 100% |
| Overweight | 0 | 0% |
| Hold | 0 | 0% |
| Underweight | 0 | 0% |
| Sell | 0 | 0% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 1.78 |

## References

- [Company Overview](https://longbridge.com/en/quote/GNPX.US/overview.md) - Shareholders, executives, business segments
- [Financials](https://longbridge.com/en/quote/GNPX.US/norm.md) - Income statement, balance sheet, cash flow, distribution plan
- [Topics & Discussions](https://longbridge.com/en/quote/GNPX.US/topics.md) - Community topics and discussions

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.
